These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36014914)

  • 21. [Scope of Mendelian randomization to control for unobserved confounding in epidemiology].
    Ancira-Moreno M; Smith N; Lamadrid-Figueroa H
    Gac Sanit; 2022; 36(3):274-277. PubMed ID: 33781616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What can Mendelian randomization contribute to biological anthropology?
    Bonilla C; Herrera G; Sans M
    Am J Biol Anthropol; 2023 Jul; 181(3):474-482. PubMed ID: 37114747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using genetic association data to guide drug discovery and development: Review of methods and applications.
    Burgess S; Mason AM; Grant AJ; Slob EAW; Gkatzionis A; Zuber V; Patel A; Tian H; Liu C; Haynes WG; Hovingh GK; Knudsen LB; Whittaker JC; Gill D
    Am J Hum Genet; 2023 Feb; 110(2):195-214. PubMed ID: 36736292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease.
    Thanassoulis G
    Can J Cardiol; 2013 Jan; 29(1):30-6. PubMed ID: 23199790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic risk factors and Mendelian randomization in cardiovascular disease.
    Swerdlow DI; Hingorani AD; Humphries SE
    Curr Cardiol Rep; 2015 May; 17(5):33. PubMed ID: 25894797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can we apply the Mendelian randomization methodology without considering epigenetic effects?
    Ogbuanu IU; Zhang H; Karmaus W
    Emerg Themes Epidemiol; 2009 May; 6():3. PubMed ID: 19432981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.
    Lawlor DA; Harbord RM; Sterne JA; Timpson N; Davey Smith G
    Stat Med; 2008 Apr; 27(8):1133-63. PubMed ID: 17886233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causal Associations Between Serum Bilirubin Levels and Decreased Stroke Risk: A Two-Sample Mendelian Randomization Study.
    Choi Y; Lee SJ; Spiller W; Jung KJ; Lee JY; Kimm H; Back JH; Lee S; Jee SH
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):437-445. PubMed ID: 31801373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An introduction to Mendelian randomization with applications in neurology.
    Allman PH; Aban IB; Tiwari HK; Cutter GR
    Mult Scler Relat Disord; 2018 Aug; 24():72-78. PubMed ID: 29960142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mendelian Randomization for the Identification of Causal Pathways in Atherosclerotic Vascular Disease.
    Jansen H; Lieb W; Schunkert H
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):41-9. PubMed ID: 26791863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
    Bowden J; Davey Smith G; Burgess S
    Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adding Mendelian randomization to a meta-analysis-a burgeoning opportunity.
    Niu W; Gu M
    Tumour Biol; 2016 Feb; 37(2):1527-9. PubMed ID: 26695146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.
    Swerdlow DI; Kuchenbaecker KB; Shah S; Sofat R; Holmes MV; White J; Mindell JS; Kivimaki M; Brunner EJ; Whittaker JC; Casas JP; Hingorani AD
    Int J Epidemiol; 2016 Oct; 45(5):1600-1616. PubMed ID: 27342221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?
    Noyce AJ; Nalls MA
    Mov Disord; 2016 Apr; 31(4):478-83. PubMed ID: 26695521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.
    Burgess S; Thompson SG
    Am J Epidemiol; 2015 Feb; 181(4):251-60. PubMed ID: 25632051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants.
    Burgess S; Bowden J; Fall T; Ingelsson E; Thompson SG
    Epidemiology; 2017 Jan; 28(1):30-42. PubMed ID: 27749700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causal graphs for the analysis of genetic cohort data.
    Hines O; Diaz-Ordaz K; Vansteelandt S; Jamshidi Y
    Physiol Genomics; 2020 Sep; 52(9):369-378. PubMed ID: 32687429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mendelian randomisation: a tool for assessing causality in observational epidemiology.
    Sheehan NA; Meng S; Didelez V
    Methods Mol Biol; 2011; 713():153-66. PubMed ID: 21153618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mendelian randomization in multiple sclerosis: A causal role for vitamin D and obesity?
    Harroud A; Richards JB
    Mult Scler; 2018 Jan; 24(1):80-85. PubMed ID: 29307294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.